D.C. Marketplace encourages labs to remove race from kidney function test to advance equity
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.
Related News Articles
Headline
The AHA's Institute for Diversity and Health Equity has extended until Oct. 15 the deadline to apply for the 2025 Carolyn Boone Lewis Equity of Care Awards,…
Headline
AnMed’s dedication to implementing language services and community engagement strategies to eliminate health care disparities and improve patient quality…
Headline
Main Line Health’s strategic collection and utilization of data, as well as its initiatives to improve the health of communities of color, earned the health…
Headline
The AHA’s 2024 Governance Survey is now available for AHA-member and non-member CEOs to complete. The survey was initially emailed to CEOs Aug. 20 and a second…
Blog
As we celebrate Hispanic Heritage Month, it's an opportune moment for us in the Hispanic community to assess our progress in health care, celebrate our…
Headline
Most maternal deaths do not occur in the hospital, but after discharge, postpartum to one year. And there are equity challenges; Black women die at three times…